The genetic architecture of human brainstem structures and their involvement in common brain disorders.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 08 2020
Historique:
received: 08 12 2019
accepted: 23 06 2020
entrez: 13 8 2020
pubmed: 13 8 2020
medline: 12 9 2020
Statut: epublish

Résumé

Brainstem regions support vital bodily functions, yet their genetic architectures and involvement in common brain disorders remain understudied. Here, using imaging-genetics data from a discovery sample of 27,034 individuals, we identify 45 brainstem-associated genetic loci, including the first linked to midbrain, pons, and medulla oblongata volumes, and map them to 305 genes. In a replication sample of 7432 participants most of the loci show the same effect direction and are significant at a nominal threshold. We detect genetic overlap between brainstem volumes and eight psychiatric and neurological disorders. In additional clinical data from 5062 individuals with common brain disorders and 11,257 healthy controls, we observe differential volume alterations in schizophrenia, bipolar disorder, multiple sclerosis, mild cognitive impairment, dementia, and Parkinson's disease, supporting the relevance of brainstem regions and their genetic architectures in common brain disorders.

Identifiants

pubmed: 32782260
doi: 10.1038/s41467-020-17376-1
pii: 10.1038/s41467-020-17376-1
pmc: PMC7421944
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4016

Investigateurs

L Farde (L)
L Flyckt (L)
G Engberg (G)
S Erhardt S (S)
H Fatouros-Bergman (H)
S Cervenka (S)
L Schwieler (L)
F Piehl (F)
I Agartz (I)
K Collste (K)
P Victorsson (P)
A Malmqvist (A)
M Hedberg (M)
F Orhan (F)
C M Sellgren (CM)

Références

Guyenet, P. G. The sympathetic control of blood pressure. Nat. Rev. Neurosci.7, 335–346 (2006).
pubmed: 16760914
Del Negro, C. A. & Funk, G. D. Breathing matters. Nat. Rev. Neurosci.19, 351–367 (2018).
pubmed: 29740175 pmcid: 6636643
Damasio, A. & Carvalho, G. B. The nature of feelings: evolutionary and neurobiological origins. Nat. Rev. Neurosci.14, 143–152 (2013).
pubmed: 23329161
Fisman, M. The brain stem in psychosis. Br. J. Psychiatry126, 414–422 (1975).
pubmed: 1125518
Williams, D. R. & Lees, A. J. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol.8, 270–279 (2009).
pubmed: 19233037
Lang, A. E. & Lozano, A. M. Parkinson’s disease. First of two parts. N. Engl. J. Med.339, 1044–1053 (1998).
pubmed: 9761807
Nestler, E. J. Is there a common molecular pathway for addiction? Nat. Neurosci.8, 1445–1449 (2005).
pubmed: 16251986
Przedborski, S. The two-century journey of Parkinson disease research. Nat. Rev. Neurosci.18, 251–259 (2017).
pubmed: 28303016
Grace, A. A. Dysregulation of the dopamine system in the pathophysiology of schizophrenia and depression. Nat. Rev. Neurosci.17, 524–532 (2016).
pubmed: 27256556 pmcid: 5166560
Krishnan, V. & Nestler, E. J. The molecular neurobiology of depression. Nature455, 894–902 (2008).
pubmed: 18923511 pmcid: 2721780
Sara, S. J. The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci.10, 211–223 (2009).
pubmed: 19190638 pmcid: 19190638
van Erp, T. G. et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol. Psychiatry21, 547–553 (2016).
pubmed: 26033243
Hibar, D. P. et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol. Psychiatry23, 932–942 (2018).
pubmed: 28461699
Whelan, C. D. et al. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain141, 391–408 (2018).
pubmed: 29365066 pmcid: 5837616
Hibar, D. P. et al. Novel genetic loci associated with hippocampal volume. Nat. Commun.8, 13624 (2017).
pubmed: 28098162 pmcid: 5253632
Hibar, D. P. et al. Common genetic variants influence human subcortical brain structures. Nature520, 224–229 (2015).
pubmed: 25607358 pmcid: 4393366
Elliott, L. T. et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature562, 210–216 (2018).
pubmed: 30305740 pmcid: 6786974
Satizabal, C. L. et al. Genetic architecture of subcortical brain structures in 38,851 individuals. Nat. Genet.51, 1624–1636 (2019).
pubmed: 31636452
Zhao, B. et al. Genome-wide association analysis of 19,629 individuals identifies variants influencing regional brain volumes and refines their genetic co-architecture with cognitive and mental health traits. Nat. Genet.51, 1637–1644 (2019).
pubmed: 31676860 pmcid: 6858580
Iglesias, J. E. et al. Bayesian segmentation of brainstem structures in MRI. Neuroimage113, 184–195 (2015).
pubmed: 25776214 pmcid: 4434226
Sudlow, C. et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med.12, e1001779 (2015).
pubmed: 25826379 pmcid: 25826379
Fischl, B. et al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron33, 341–355 (2002).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet.81, 559–575 (2007).
pubmed: 17701901 pmcid: 17701901
van der Meer, D., Rokicki, J., Kaufmann, T., Córdova-Palomera, A. & Moberget, T. Brain scans from 21,297 individuals reveal the genetic architecture of hippocampal subfield volumes. Mol. Psychiatry https://doi.org/10.1038/s41380-41018-40262-41387 (2018). [Online ahead of print].
doi: 10.1038/s41380-41018-40262-41387 pubmed: 30283035 pmcid: 7042770
Yang, J., Lee, S. H., Goddard, M. E. & Visscher, P. M. GCTA: a tool for genome-wide complex trait analysis. Am. J. Hum. Genet.88, 76–82 (2011).
pubmed: 21167468 pmcid: 3014363
Watanabe, K., Taskesen, E., van Bochoven, A. & Posthuma, D. Functional mapping and annotation of genetic associations with FUMA. Nat. Commun.8, 1826 (2017).
pubmed: 29184056 pmcid: 5705698
Ernst, J. & Kellis, M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods9, 215–216 (2012).
pubmed: 22373907 pmcid: 3577932
Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet.46, 310–315 (2014).
pubmed: 24487276 pmcid: 3992975
Pickrell, J. K. et al. Detection and interpretation of shared genetic influences on 42 human traits. Nat. Genet.48, 709–717 (2016).
pubmed: 27182965 pmcid: 5207801
de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol.11, e1004219 (2015).
pubmed: 25885710 pmcid: 4401657
Trainor, P. A. & Krumlauf, R. Patterning the cranial neural crest: hindbrain segmentation and Hox gene plasticity. Nat. Rev. Neurosci.1, 116–124 (2000).
pubmed: 11252774
Kamburov, A., Stelzl, U., Lehrach, H. & Herwig, R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res41, D793–D800 (2013).
pubmed: 23143270
Andreassen, O. A. et al. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. Am. J. Hum. Genet.92, 197–209 (2013).
pubmed: 23375658 pmcid: 3567279
Schork, A. J., Wang, Y., Thompson, W. K., Dale, A. M. & Andreassen, O. A. New statistical approaches exploit the polygenic architecture of schizophrenia–—implications for the underlying neurobiology. Curr. Opin. Neurobiol.36, 89–98 (2016).
pubmed: 26555806
Smeland, O. B. et al. Discovery of shared genomic loci using the conditional false discovery rate approach. Hum. Genet.139, 85–94 (2020).
pubmed: 31520123
Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet.47, 1236–1241 (2015).
pubmed: 26414676 pmcid: 4797329
R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. (2013).
Melin, B. S. et al. Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors. Nat. Genet.49, 789–794 (2017).
pubmed: 28346443 pmcid: 5558246
Baselmans, B. M. L. et al. Multivariate genome-wide analyses of the well-being spectrum. Nat. Genet.51, 445–451 (2019).
pubmed: 30643256
Dyer, A. H., Vahdatpour, C., Sanfeliu, A. & Tropea, D. The role of insulin-like growth factor 1 (IGF-1) in brain development, maturation and neuroplasticity. Neuroscience325, 89–99 (2016).
pubmed: 27038749
Guan, J. J. et al. DRAM1 regulates apoptosis through increasing protein levels and lysosomal localization of BAX. Cell. Death. Dis.6, e1624 (2015).
pubmed: 25633293 pmcid: 4669745
Garcia-Fernandez, J. The genesis and evolution of homeobox gene clusters. Nat. Rev. Genet.6, 881–892 (2005).
pubmed: 16341069
Doucet-Beaupre, H., Ang, S. L. & Levesque, M. Cell fate determination, neuronal maintenance and disease state: The emerging role of transcription factors Lmx1a and Lmx1b. FEBS Lett.589, 3727–3738 (2015).
pubmed: 26526610
Hwang, J. Y. & Zukin, R. S. REST, a master transcriptional regulator in neurodegenerative disease. Curr. Opin. Neurobiol.48, 193–200 (2018).
pubmed: 29351877 pmcid: 5892838
Köhler, M. et al. Small-conductance, calcium-activated potassium channels from mammalian brain. Science273, 1709–1714 (1996).
pubmed: 8781233
Zollino, M. et al. Mutations in KANSL1 cause the 17q21.31 microdeletion syndrome phenotype. Nat. Genet.44, 636–638 (2012).
pubmed: 22544367
Frei, O. et al. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation. Nat. Commun.10, 2417 (2019).
pubmed: 31160569 pmcid: 6547727
Schildkraut, J. J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am. J. Psychiatry122, 509–522 (1965).
pubmed: 5319766
Rimol, L. M. et al. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biol. Psychiatry68, 41–50 (2010).
pubmed: 20609836
Alnaes, D. et al. Brain heterogeneity in schizophrenia and its association with polygenic risk. JAMA Psychiatry76, 739–748 (2019).
pubmed: 30969333 pmcid: 6583664
Ledig, C., Schuh, A., Guerrero, R., Heckemann, R. A. & Rueckert, D. Structural brain imaging in Alzheimer’s disease and mild cognitive impairment: biomarker analysis and shared morphometry database. Sci. Rep.8, 11258 (2018).
pubmed: 30050078 pmcid: 6062561
Nigro, S. et al. Fully automated segmentation of the pons and midbrain using human T1 MR brain images. PLoS One9, e85618 (2014).
pubmed: 24489664 pmcid: 3904850
Daams, M. et al. Unraveling the neuroimaging predictors for motor dysfunction in long-standing multiple sclerosis. Neurology85, 248–255 (2015).
pubmed: 26115736
Lee, C. Y. et al. Differential brainstem atrophy patterns in multiple sclerosis and neuromyelitis optica spectrum disorders. J. Magn. Reson. Imaging47, 1601–1609 (2018).
pubmed: 28990252
Rektorova, I. et al. Grey matter changes in cognitively impaired Parkinson’s disease patients. PLoS One9, e85595 (2014).
pubmed: 24465612 pmcid: 3897481
Sawczak, C. M., Barnett, A. J. & Cohn, M. Increased cortical thickness in attentional networks in Parkinson’s disease with minor hallucinations. Parkinsons Dis.2019, 5351749 (2019).
pubmed: 31191901 pmcid: 6525808
Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res.22, 1790–1797 (2012).
pubmed: 22955989 pmcid: 3431494
Ernst, J. & Kellis, M. Chromatin-state discovery and genome annotation with ChromHMM. Nat. Protoc.12, 2478–2492 (2017).
pubmed: 29120462 pmcid: 29120462
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA102, 15545–15550 (2005).
pubmed: 16199517
Demontis, D. et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nat. Genet.51, 63–75 (2019).
pubmed: 30478444
Ripke, S. et al. Biological insights from 108 schizophrenia-associated genetic loci. Nature511, 421–427 (2014).
pmcid: 4112379
The Autism Spectrum Disorders Working Group of The Psychiatric Genomics Consortium. Meta-analysis of GWAS of over 16,000 individuals with autism spectrum disorder highlights a novel locus at 10q24.32 and a significant overlap with schizophrenia. Mol. Autism. 8, 21 (2017).
Stahl, E. A. et al. Genome-wide association study identifies 30 loci associated with bipolar disorder. Nat. Genet.51, 793–803 (2019).
pubmed: 31043756 pmcid: 6956732
Wray, N. R. et al. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat. Genet.50, 668–681 (2018).
pubmed: 29700475 pmcid: 5934326
Hyde, C. L. et al. Identification of 15 genetic loci associated with risk of major depression in individuals of European descent. Nat. Genet.48, 1031–1036 (2016).
pubmed: 27479909 pmcid: 5706769
Lambert, J. C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat. Genet.45, 1452–1458 (2013).
pubmed: 24162737 pmcid: 3896259
Sawcer, S. et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature476, 214–219 (2011).
pubmed: 21833088 pmcid: 3182531
Chang, D. et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson’s disease risk loci. Nat. Genet.49, 1511–1516 (2017).
pubmed: 28892059 pmcid: 5812477
Nalls, M. A. et al. Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease. Nat. Genet.46, 989–993 (2014).
pubmed: 25064009 pmcid: 4146673
Goetz, C. G. et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord.23, 2129–2170 (2008).
pubmed: 19025984

Auteurs

Torbjørn Elvsåshagen (T)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. torbjorn.elvsashagen@medisin.uio.no.
Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway. torbjorn.elvsashagen@medisin.uio.no.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway. torbjorn.elvsashagen@medisin.uio.no.

Shahram Bahrami (S)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. shahram.bahrami@medisin.uio.no.

Dennis van der Meer (D)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
School of Mental Health and Neuroscience, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

Ingrid Agartz (I)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.
NORMENT, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Dag Alnæs (D)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Deanna M Barch (DM)

Departments of Psychological & Brain Sciences, Psychiatry, and Radiology, Washington University in St. Louis, St. Louis, USA.

Ramona Baur-Streubel (R)

Department of Psychology I and Centre of Mental Health, University of Würzburg, Würzburg, Germany.

Alessandro Bertolino (A)

Institute of Psychiatry, University of Bari, Bari, Italy.
Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Mona K Beyer (MK)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Giuseppe Blasi (G)

Institute of Psychiatry, University of Bari, Bari, Italy.
Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Stefan Borgwardt (S)

Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.
Institute of Psychiatry, King's College, London, UK.
Department of Psychiatry and Psychotherapy, University of Lübeck, Lübeck, Germany.

Birgitte Boye (B)

Psychosomatic and CL Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Behavioural Sciences in Medicine, University of Oslo, Oslo, Norway.

Jan Buitelaar (J)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
Karakter Child and Adolescent Psychiatry University Centre, Nijmegen, The Netherlands.

Erlend Bøen (E)

Psychosomatic and CL Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Elisabeth Gulowsen Celius (EG)

Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Simon Cervenka (S)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.

Annette Conzelmann (A)

Children and Adolescence Psychiatry, University of Tübingen, Tübingen, Germany.

David Coynel (D)

Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, CH-4055, Basel, Switzerland.
Division of Cognitive Neuroscience, Department of Psychology, University of Basel, CH-4055 Basel, Switzerland.

Pasquale Di Carlo (P)

Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Srdjan Djurovic (S)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.

Sarah Eisenacher (S)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Institute of Psychiatric and Psychosomatic Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Thomas Espeseth (T)

Department of Psychology, University of Oslo, Oslo, Norway.
Bjørknes College, Lovisenberggata, 13, 0456, Oslo, Norway.

Helena Fatouros-Bergman (H)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.

Lena Flyckt (L)

Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.

Barbara Franke (B)

Departments of Human Genetics and Psychiatry, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Oleksandr Frei (O)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Barbara Gelao (B)

Institute of Psychiatry, University of Bari, Bari, Italy.

Hanne Flinstad Harbo (HF)

Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Catharina A Hartman (CA)

Department of Psychiatry, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Asta Håberg (A)

Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Radiology and Nuclear Medicine, St. Olavs Hospital, Trondheim, Norway.

Dirk Heslenfeld (D)

Clinical Neuropsychology section, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Department of Cognitive Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.

Pieter J Hoekstra (PJ)

Department of Child and Adolescent Psychiatry, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Einar A Høgestøl (EA)

Department of Neurology, Division of Clinical Neuroscience, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Rune Jonassen (R)

Department of Psychology, University of Oslo, Oslo, Norway.
Faculty of Health Sciences, Oslo Metropolitan University, Oslo, Norway.

Erik G Jönsson (EG)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet & Stockholm Health Care Services, Stockholm Region, Stockholm, Sweden.

Peter Kirsch (P)

Department of Clinical Psychology, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Bernstein Center for Computational Neuroscience Heidelberg/Mannheim, Mannheim, Germany.

Iwona Kłoszewska (I)

Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland.

Trine Vik Lagerberg (TV)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Nils Inge Landrø (NI)

Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Stephanie Le Hellard (S)

NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.

Klaus-Peter Lesch (KP)

Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
Laboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.
Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience (MHeNS), Maastricht University, Maastricht, The Netherlands.

Luigi A Maglanoc (LA)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Ulrik F Malt (UF)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Patrizia Mecocci (P)

Institute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.

Ingrid Melle (I)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Andreas Meyer-Lindenberg (A)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Torgeir Moberget (T)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Jan Egil Nordvik (JE)

The CatoSenteret Rehabilitation Center, Son, Norway.

Lars Nyberg (L)

Departments of Radiation Sciences and Integrative Medical Biology, Umeå Center for Functional Brain Imaging, Umeå University, Umeå, Sweden.

Kevin S O' Connell (KSO)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Jaap Oosterlaan (J)

Clinical Neuropsychology section, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Emma Children's Hospital Amsterdam UMC, University of Amsterdam, Emma Neuroscience Group, Department of Pediatrics, Amsterdam Reproduction & Development, Amsterdam, The Netherlands.

Marco Papalino (M)

Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Andreas Papassotiropoulos (A)

Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, CH-4055, Basel, Switzerland.
Division of Cognitive Neuroscience, Department of Psychology, University of Basel, CH-4055 Basel, Switzerland.
Psychiatric University Clinics, University of Basel, Basel, Switzerland.
Department Biozentrum, Life Sciences Training Facility, University of Basel, Basel, Switzerland.

Paul Pauli (P)

Department of Psychology I and Centre of Mental Health, University of Würzburg, Würzburg, Germany.

Giulio Pergola (G)

Department of Basic Medical Science, Neuroscience, and Sense Organs, University of Bari Aldo Moro, Bari, Italy.

Karin Persson (K)

Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.

Dominique de Quervain (D)

Transfaculty Research Platform Molecular and Cognitive Neurosciences, University of Basel, CH-4055, Basel, Switzerland.
Division of Cognitive Neuroscience, Department of Psychology, University of Basel, CH-4055 Basel, Switzerland.
Psychiatric University Clinics, University of Basel, Basel, Switzerland.

Andreas Reif (A)

Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt am Main, Germany.

Jaroslav Rokicki (J)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Daan van Rooij (D)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Alexey A Shadrin (AA)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

André Schmidt (A)

Department of Psychiatry (UPK), University of Basel, Basel, Switzerland.

Emanuel Schwarz (E)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.

Geir Selbæk (G)

Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Geriatric Medicine, Oslo University Hospital, Oslo, Norway.
Norwegian National Advisory Unit on Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.

Hilkka Soininen (H)

Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Neurocenter, Neurology, Kuopio University Hospital, Kuopio, Finland.

Piotr Sowa (P)

Division of Radiology and Nuclear Medicine, Oslo University Hospital, Oslo, Norway.

Vidar M Steen (VM)

NORMENT, Department of Clinical Science, University of Bergen, Bergen, Norway.
Dr. E. Martens Research Group for Biological Psychiatry, Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Magda Tsolaki (M)

1st University Department of Neurology, Aristotle University of Thessaloniki, Makedonia, Greece.

Bruno Vellas (B)

INSERM U 1027, University of Toulouse, Toulouse, France.

Lei Wang (L)

Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Eric Westman (E)

Institute of Psychiatry, King's College, London, UK.
Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Stockholm, Sweden.

Georg C Ziegler (GC)

Division of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.

Mathias Zink (M)

Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
District hospital Mittelfranken, Ansbach, Germany.

Ole A Andreassen (OA)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Lars T Westlye (LT)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Psychology, University of Oslo, Oslo, Norway.

Tobias Kaufmann (T)

NORMENT, Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway. tobias.kaufmann@medisin.uio.no.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway. tobias.kaufmann@medisin.uio.no.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH